Antidepressant-like effects of Albizzia julibrissin in mice: Involvement of the 5-HT1A receptor system

Research output: Contribution to journalArticlepeer-review

Abstract

The present study was undertaken to investigate the antidepressant-like effects of the methylene chloride fraction of Albizzia julibrissin (MCAJ) using a tail suspension test in mice. MCAJ was orally administered at 50, 100, or 200 mg/kg to mice, 1 h before the tail suspension test. Acute treatment with MCAJ at 200 mg/kg significantly reduced the immobility time compared with the control group, and thus showed an antidepressant-like effect. This effect was comparable to that of imipramine at 10 mg/kg. This antidepressant-like effect was reversed by treatment with WAY-100635 (a 5-HT1A receptor antagonist) or pindolol (a 5-HT1A/1B receptor antagonist). However, the antidepressant effect of MCAJ was not effected by treatment with GR55562 (a 5-HT1B receptor antagonist) or ketanserin (a 5-HT2A receptor antagonist). Therefore, our findings suggest that MCAJ exerts its antidepressant-like effect via the 5-HT1A receptor system.

Original languageEnglish
Pages (from-to)41-47
Number of pages7
JournalPharmacology Biochemistry and Behavior
Volume87
Issue number1
DOIs
StatePublished - May 2007

Keywords

  • 5-HT receptor
  • Albizzia julibrissin
  • Depression
  • Mice
  • Tail suspension

Fingerprint

Dive into the research topics of 'Antidepressant-like effects of Albizzia julibrissin in mice: Involvement of the 5-HT1A receptor system'. Together they form a unique fingerprint.

Cite this